NCT00023647View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

April 30, 2002

Study Completion Date

November 30, 2002

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

Synchrotope TA2M

Cancer Vaccine, Immunotherapy

BIOLOGICAL

Synchrotope TA2M

Cancer Vaccine, Immunotherapy

BIOLOGICAL

Synchrotope TA2M

Cancer Vaccine, Immunotherapy

Trial Locations (1)

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY